Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Evome Medical Technologies Inc. (LNDZF)
Shirley, NY, US
Evome Medical Technologies Inc. is a global company that conceives, produces, and markets medical equipment across the Americas and other international markets. The firm's diverse array of products is primarily focused on pain alleviation and physical restoration therapies. This broad selection includes specialized instruments like dynamometers for measuring muscle strength, advanced systems for gait training, tools for balance evaluation and re-establishment, electrical stimulation devices (both neuromuscular and transcutaneous), ultrasonic therapeutic equipment, and cutting-edge wearable technologies. All these innovations are designed to bolster human health by assisting in preventative care, therapeutic interventions, and rehabilitation efforts.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|
| Revenue |
-33.5K
est: 17.10M (-100.2%)
|
18.31M
est: 65.22M (-71.9%)
|
62.63M
est: 67.94M (-7.8%)
|
62.17M
est.
|
| EBITDA |
-1.44M
est: -1.64M (+12.4%)
|
-3.24M
est: -6.15M (+47.3%)
|
-10.42M
est: -6.41M (-62.6%)
|
-5.86M
est.
|
| EBIT |
-2.28M
est: -2.12M (-7.5%)
|
-4.09M
est: -8.33M (+51.0%)
|
-12.91M
est: -8.68M (-48.7%)
|
-7.94M
est.
|
| Net Income |
-2.67M
est: -3.32M (+19.7%)
|
-4.37M
est: 5.10M (-185.8%)
|
-15.60M
est: -752.4K (-1,973.6%)
|
-3.67M
est.
|
| SGA |
990.3K
est: -81.97M (+101.2%)
|
5.73M
est: -296.74M (+101.9%)
|
24.16M
est: -309.11M (+107.8%)
|
-282.86M
est.
|
| EPS |
-0.06
est: -0.05 (-35.1%)
|
-0.10
est: 0.07 (-244.1%)
|
-0.16
est: -0.01 (-1,464.8%)
|
-0.05
est.
|
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LNDZF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
